Published in Ann Surg on March 01, 2012
Interstage Assessment of Remnant Liver Function in ALPPS | NCT02846441
ALPPS: Safety, Feasibility and Efficacy at a Single Center | NCT02164292
Cholangiocarcinoma. Lancet (2014) 4.52
Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg (2012) 3.87
ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg (2014) 3.60
Simplifying the ALPPS procedure by the anterior approach. Ann Surg (2014) 2.22
Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy. J Am Coll Surg (2014) 1.76
ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence. World J Surg (2014) 1.66
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? Ann Surg (2012) 1.55
Variation on a Theme: Alternative to Plastic Bag in ALPPS Procedures: Feasibility and Clinical Safety of COVA+™ Membrane in ALPPS Procedures. World J Surg (2015) 1.39
The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int (2014) 1.25
The ALPPS procedure for extended indications in liver surgery: an old finding applied in surgical oncology. Ann Surg (2013) 1.19
ALPPS: Adverse Outcomes Demand Clear Justification in an Era of Improving Survival for Colorectal Liver Metastases. World J Surg (2015) 1.18
Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections. J Gastrointest Surg (2012) 1.14
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) (2013) 1.08
Which limits to the "ALPPS" approach? Ann Surg (2012) 1.03
Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg (2012) 1.03
The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion. World J Surg (2014) 1.01
Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Eur Radiol (2017) 0.98
Current position of ALPPS in the surgical landscape of CRLM treatment proposals. World J Gastroenterol (2013) 0.97
Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol (2014) 0.97
Long-term results with associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Surg (2012) 0.96
Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive first-step approach. Ann Surg (2015) 0.95
Post-hepatectomy liver failure. Hepatobiliary Surg Nutr (2014) 0.94
Totally laparoscopic ALPPS in the treatment of cirrhotic hepatocellular carcinoma. Surg Endosc (2014) 0.93
Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. HPB (Oxford) (2015) 0.92
Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review. World J Gastroenterol (2015) 0.91
Liver function following extended hepatectomy can be accurately predicted using remnant liver volume to body weight ratio. World J Surg (2015) 0.90
Clinical implications of advances in liver regeneration. Clin Mol Hepatol (2015) 0.90
Portal vein embolization for hepatocellular carcinoma. Liver Cancer (2012) 0.90
Monitoring of liver function in a 73-year old patient undergoing 'Associating Liver Partition and Portal vein ligation for Staged hepatectomy': case report applying the novel liver maximum function capacity test. Patient Saf Surg (2016) 0.90
Assessment of Liver Function Using (99m)Tc-Mebrofenin Hepatobiliary Scintigraphy in ALPPS (Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy). Case Rep Gastroenterol (2015) 0.89
Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol (2015) 0.89
Liver resection for colorectal cancer metastases. Curr Oncol (2013) 0.89
Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol (2016) 0.89
Avoid "All-Touch" by Hybrid ALPPS to Achieve Oncological Efficacy. Ann Surg (2016) 0.88
Little girl who conquered the "ALPPS''. World J Gastroenterol (2014) 0.88
Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88
Small for size liver remnant following resection: prevention and management. Hepatobiliary Surg Nutr (2014) 0.87
Update on the management of cholangiocarcinoma. Dig Dis (2014) 0.87
Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases. HPB (Oxford) (2013) 0.87
ALPPS and simultaneous right hemicolectomy - step one and resection of the primary colon cancer. World J Surg Oncol (2015) 0.86
ALPPS Procedure for Extended Liver Resections: A Single Centre Experience and a Systematic Review. PLoS One (2015) 0.86
Laparoscopic portal vein ligation with in situ liver split for failed portal vein embolization. Ann Surg (2012) 0.85
Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis. World J Gastroenterol (2016) 0.85
Associating liver partition and portal vein ligation for staged hepatectomy: will the morbidity of an additional surgery be outweighed by better patient outcomes in the long-term? Ann Surg (2012) 0.85
Patient Survival After Simultaneous ALPPS and Colorectal Resection. World J Surg (2016) 0.85
Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy. World J Hepatol (2016) 0.84
Tumour progression and liver regeneration--insights from animal models. Nat Rev Gastroenterol Hepatol (2013) 0.84
Current diagnostic and management options in perihilar cholangiocarcinoma. Digestion (2014) 0.84
In situ split of the liver when portal venous embolization fails to induce hypertrophy: a report of two cases. Case Rep Surg (2013) 0.84
Safety and feasibility of an enhanced recovery pathway after a liver resection: prospective cohort study. HPB (Oxford) (2015) 0.84
Rescue ALPPS: Intraoperative Conversion to ALPPS during Synchronous Resection of Rectal Cancer and Liver Metastasis. Case Rep Surg (2014) 0.84
Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases. Surg Endosc (2014) 0.82
ALPPS: PAST, PRESENT AND FUTURE. Arq Bras Cir Dig (2015) 0.81
The ALPPS procedure for hepatocellular carcinoma larger than 10 centimeters. Int J Surg Case Rep (2016) 0.81
Note from the editors on the ALPPS e-Letters-to-the-Editor. Ann Surg (2012) 0.81
Update in management of hepatocellular carcinoma in Eastern population. World J Hepatol (2015) 0.81
An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence. Medicine (Baltimore) (2016) 0.80
Establishment of a rat model of portal vein ligation combined with in situ splitting. PLoS One (2014) 0.80
Liver function impairment in liver transplantation and after extended hepatectomy. World J Gastroenterol (2013) 0.80
Intraoperative functional liver remnant assessment with indocyanine green clearance: another toehold for climbing the “ALPPS”. Ann Surg (2015) 0.80
ALPPS: Short-term Outcome and Functional Changes in the Future Liver Remnant. Ann Surg (2015) 0.80
Identification of cofactors influencing hypertrophy of the future liver remnant after portal vein embolization-the effect of collaterals on embolized liver volume. Br J Radiol (2016) 0.80
Combination of in situ split and portal ligation: lights and shadows of a new surgical procedure. Ann Surg (2012) 0.79
Are two-stage hepatectomies associated with more complications than one-stage procedures? HPB (Oxford) (2012) 0.79
Strategies for Management of Synchronous Colorectal Metastases. Curr Surg Rep (2014) 0.79
Improved liver function after portal vein embolization and an elective right hepatectomy. HPB (Oxford) (2015) 0.79
Is there new hope for patients with marginally resectable liver malignancies. World J Gastrointest Surg (2012) 0.79
The ALPPS approach: should we sacrifice basic therapeutic rules in the name of innovation? World J Surg (2014) 0.79
Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg (2014) 0.79
Liver resection with concomitant inferior vena cava resection: experiences without veno-venous bypass. Surg Today (2013) 0.79
Long-term results after in-situ split (ISS) liver resection. Langenbecks Arch Surg (2015) 0.78
Two-stage hepatectomy for liver metastasis from colorectal cancer. CMAJ (2014) 0.78
How we do it: double in situ split for staged mesohepatectomy in patients with advanced gall bladder cancer and marginal future liver remnant. Langenbecks Arch Surg (2016) 0.78
A novel rat model of liver regeneration: possible role of cytokine induced neutrophil chemoattractant-1 in augmented liver regeneration. Ann Surg Innov Res (2015) 0.78
Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg (2016) 0.78
Improving the quality of liver resection: a systematic review and critical analysis of the available prognostic models. HPB (Oxford) (2014) 0.78
Clinical guideline SEOM: hepatocellular carcinoma. Clin Transl Oncol (2015) 0.78
Post-hepatectomy liver failure in patients with colorectal liver metastases. Surg Today (2015) 0.78
The surgical treatment of patients with colorectal cancer and liver metastases in the setting of the "liver first" approach. Hepatobiliary Surg Nutr (2014) 0.78
Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma. Langenbecks Arch Surg (2015) 0.78
Associated Liver Partition and Portal Vein Ligation (ALPPS) vs Selective Portal Vein Ligation (PVL) for Staged Hepatectomy in a Rat Model. Similar Regenerative Response? PLoS One (2015) 0.78
Indications, limitations and maneuvers to enable extended hepatectomy: current trends. World J Gastroenterol (2014) 0.78
Surgery of Colorectal Liver Metastases: Pushing the Limits. Liver Cancer (2016) 0.78
Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease. Curr Colorectal Cancer Rep (2015) 0.78
Characterization of a porcine model for associating liver partition and portal vein ligation for a staged hepatectomy. HPB (Oxford) (2015) 0.78
The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry. HPB (Oxford) (2016) 0.77
Laparoscopic hepatectomy by curettage and aspiration: a report of 855 cases. Surg Endosc (2015) 0.77
Reply to letter: "The ALPPS procedure for extended indications in liver surgery: an old finding applied in surgical oncology". Ann Surg (2013) 0.77
Intrahepatic Vascular Anatomy in Rats and Mice-Variations and Surgical Implications. PLoS One (2015) 0.77
Assessment of Liver Remnant Using ICG Clearance Intraoperatively during Vascular Exclusion: Early Experience with the ALIIVE Technique. HPB Surg (2015) 0.77
Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins. Langenbecks Arch Surg (2015) 0.77
Surgical options for initially unresectable colorectal liver metastases. HPB Surg (2012) 0.77
Associating liver partition and portal vein ligation for a patient with hepatocellular carcinoma with a background of hepatitis B related fibrotic liver. Int J Surg Case Rep (2014) 0.77
Rapid improvement in liver volume induced by portal vein ligation and staged hepatectomy: the ALPPS procedure. HPB (Oxford) (2012) 0.77
Evaluating surgeon attitudes towards the safety and efficacy of portal vein occlusion and associating liver partition and portal vein ligation: a report of the MALINSA survey. HPB (Oxford) (2015) 0.77
Right hepatic artery crossing the common hepatic artery: an unusual blood supply to the liver. Surg Radiol Anat (2015) 0.77
Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique. Langenbecks Arch Surg (2016) 0.76
Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications. Virchows Arch (2014) 0.76
Minor-but-Complex Liver Resection: An Alternative to Major Resections for Colorectal Liver Metastases Involving the Hepato-Caval Confluence. Medicine (Baltimore) (2015) 0.76
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol (2009) 5.57
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest (2004) 5.14
Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol (2009) 4.38
ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg (2014) 3.60
A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med (2006) 3.24
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature (2012) 3.23
Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl (2002) 2.86
A new endoscopic over-the-scope clip system for treatment of lesions and bleeding in the GI tract: first clinical experiences. Gastrointest Endosc (2007) 2.72
OX40 costimulation turns off Foxp3+ Tregs. Blood (2007) 2.52
Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes (2009) 2.36
Regulation of AID expression in the immune response. J Exp Med (2007) 2.35
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer (2009) 2.26
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res (2006) 2.26
Functional importance of laparoscopic sleeve gastrectomy for the lower esophageal sphincter in patients with morbid obesity. Obes Surg (2012) 2.11
Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol (2007) 2.02
Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem (2009) 2.02
Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept. Transpl Int (2010) 1.99
The Over-The-Scope Clip (OTSC) for the treatment of gastrointestinal bleeding, perforations, and fistulas. Surg Endosc (2011) 1.98
Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int (2008) 1.95
Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci U S A (2011) 1.89
Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol (2007) 1.88
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol Immunother (2008) 1.88
The White test: a new dye test for intraoperative detection of bile leakage during major liver resection. Arch Surg (2008) 1.86
Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Gut (2011) 1.84
Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr (2008) 1.78
A new wound-based severity score for diabetic foot ulcers: A prospective analysis of 1,000 patients. Diabetes Care (2006) 1.78
Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Int J Cancer (2005) 1.73
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol (2007) 1.71
Pivotal Advance: Up-regulation of acetylcholine synthesis and paracrine cholinergic signaling in intravascular transplant leukocytes during rejection of rat renal allografts. J Leukoc Biol (2009) 1.67
Living-related liver transplantation from the view of the donor: a 1-year follow-up survey. Transplantation (2002) 1.66
NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest (2010) 1.64
Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation (2006) 1.64
Primary malignant sarcomas of the heart and great vessels in adult patients--a single-center experience. Oncologist (2007) 1.63
Fatal pneumonia caused by Panton-Valentine Leucocidine-positive methicillin-resistant Staphylococcus aureus (PVL-MRSA) transmitted from a healthy donor in living-donor liver transplantation. Transplantation (2006) 1.63
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol (2009) 1.62
Intestinal ischemia: current treatment concepts. Langenbecks Arch Surg (2010) 1.60
Multiparameter immunofluorescence on paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol (2006) 1.59
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) (2009) 1.57
Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation. J Hepatol (2013) 1.56
Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection. Pediatr Transplant (2008) 1.56
Strong predictors for alcohol recidivism after liver transplantation: non-acceptance of the alcohol problem and abstinence of <3 months. Scand J Gastroenterol (2011) 1.55
Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med (2003) 1.55
Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology (2003) 1.53
Quality of life and functional long-term outcome after partial pancreatoduodenectomy: pancreatogastrostomy versus pancreatojejunostomy. Ann Surg Oncol (2005) 1.52
Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer. World J Surg (2012) 1.50
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis (2015) 1.47
Mental and physical quality of life in actual living liver donors versus potential living liver donors: a prospective, controlled, multicenter study. Liver Transpl (2009) 1.47
Simultaneous adrenal and extra-adrenal myelolipoma - an uncommon incident: case report and review of the literature. World J Surg Oncol (2008) 1.46
C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation. Transplantation (2002) 1.45
The value of a noninvasive diagnostic approach to mediastinal masses. Ann Thorac Surg (2003) 1.44
Hilar early division of the hepatic duct in living donor right hepatectomy: the probe-and-clamp technique. Liver Transpl (2006) 1.44
Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant (2007) 1.43
Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics. Cancer Invest (2012) 1.42
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice. J Gastroenterol Hepatol (2010) 1.42
Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers: a randomized, controlled, multicenter study. J Vasc Surg (2006) 1.42
Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations. Transplantation (2002) 1.41
Does PEEP impair the hepatic outflow in patients following liver transplantation? Intensive Care Med (2006) 1.41
Markers of Bone Metabolism in Obese Individuals Undergoing Laparoscopic Sleeve Gastrectomy. Obes Surg (2015) 1.41
The impact of a micro-lightguide spectrophotometer on the intraoperative assessment of hepatic microcirculation: a pilot study. Microvasc Res (2009) 1.41
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation (2004) 1.40
Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care (2009) 1.40
Outcome after kidney transplantation in children with thrombotic risk factors. Pediatr Transplant (2006) 1.39
Adenocarcinoma arising in a cystic duplication of the small bowel: case report and review of literature. World J Surg Oncol (2012) 1.38
Minimally invasive versus open esophagectomy: meta-analysis of outcomes. Dig Dis Sci (2010) 1.35
New indications for computer-assisted surgery: tumor resection in the pelvis. Clin Orthop Relat Res (2004) 1.35
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol (2009) 1.34
The liver: a special case in transplantation tolerance. Semin Liver Dis (2007) 1.33
Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol (2012) 1.32
ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure? J Gastrointest Surg (2013) 1.32
Right living donor liver transplantation: an option for adult patients: single institution experience with 74 patients. Ann Surg (2003) 1.31
Achalasia: will genetic studies provide insights? Hum Genet (2010) 1.30
Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl (2006) 1.30
Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Mol Cancer Ther (2007) 1.29
Surgical strategy in aortoesophageal fistulae: endovascular stentgrafts and in situ repair of the aorta with cryopreserved homografts. Ann Surg (2007) 1.29
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27
Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer. Mol Cancer Ther (2011) 1.26
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol (2011) 1.25
Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages. J Clin Invest (2011) 1.25
Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. J Clin Endocrinol Metab (2011) 1.24
mTOR, cancer and transplantation. Am J Transplant (2008) 1.24
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol (2011) 1.20